Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

New England Journal of Medicine - Tập 367 Số 19 - Trang 1783-1791 - 2012
Sunil Verma1, David Miles2, Luca Gianni3, Ian E. Krop4, Manfred Welslau5, José Baselga6, Mark D. Pegram7, Do‐Youn Oh8, Véronique Dièras9, Ellie Guardino10, Fang Ting Liang10, Michael W. Lu10, Steven R. Olsen10, Kim T. Blackwell11
1Sunnybrook Odette Cancer Centre, Toronto
2Mount Vernon Cancer Centre, Northwood, United Kingdom
3San Raffaele Hospital, Milan
4Dana Farber Cancer Institute
5Medical Office Hematology, Aschaffenburg, Germany
6Massachusetts General Hospital
7University of Miami Sylvester Comprehensive Cancer Center, Miami
8Seoul National University College of Medicine, Seoul, South Korea
9Institut Curie, Paris
10Genentech, South San Francisco, CA
11Duke University Medical Center, Durham, NC

Tóm tắt

Từ khóa


Tài liệu tham khảo

10.1126/science.3798106

10.1634/theoncologist.2008-0230

10.1200/JCO.2008.19.9844

10.1056/NEJM200103153441101

10.1200/JCO.2005.04.173

10.1056/NEJMoa064320

10.1158/0008-5472.CAN-08-1776

10.1007/s10549-010-1090-x

10.1200/JCO.2011.40.5902

10.1200/JCO.2010.29.5865

10.1093/jnci/92.3.205

Brady MJ, 1997, J Clin Oncol, 15, 974, 10.1200/JCO.1997.15.3.974

Thông tin
Thông tin xuất bản

New England Journal of Medicine

Tập 367 Số 19

1783-1791

Thông tin tác giả